Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
复制标题
二甲双胍抑制尿素循环并减少结直肠癌细胞系中腐胺的产生
DOI：
10.3390/molecules26071990
复制
发表时间：
2021-04-01
期刊：
影响因子：
--
通讯作者：
Ran JH
中科院分区：
文献类型：
--
作者：
Zhang T;Hu L;Tang JF;Xu H;Tian K;Wu MN;Huang SY;Du YM;Zhou P;Lu RJ;He S;Xu JM;Si JJ;Li J;Chen DL;Ran JH
The urea cycle (UC) removes the excess nitrogen and ammonia generated by nitrogen-containing compound composites or protein breakdown in the human body. Research has shown that changes in UC enzymes are not only related to tumorigenesis and tumor development but also associated with poor survival in hepatocellular, breast, and colorectal cancers (CRC), etc. Cytoplasmic ornithine, the intermediate product of the urea cycle, is a specific substrate for ornithine decarboxylase (ODC, also known as ODC1) for the production of putrescine and is required for tumor growth. Polyamines (spermidine, spermine, and their precursor putrescine) play central roles in more than half of the steps of colorectal tumorigenesis. Given the close connection between polyamines and cancer, the regulation of polyamine metabolic pathways has attracted attention regarding the mechanisms of action of chemical drugs used to prevent CRC, as the drug most widely used for treating type 2 diabetes (T2D), metformin (Met) exhibits antitumor activity against a variety of cancer cells, with a vaguely defined mechanism. In addition, the influence of metformin on the UC and putrescine generation in colorectal cancer has remained unclear. In our study, we investigated the effect of metformin on the UC and putrescine generation of CRC in vivo and in vitro and elucidated the underlying mechanisms. In nude mice bearing HCT116 tumor xenografts, the administration of metformin inhibited tumor growth without affecting body weight. In addition, metformin treatment increased the expression of monophosphate (AMP)-activated protein kinase (AMPK) and p53 in both HCT116 xenografts and colorectal cancer cell lines and decreased the expression of the urea cycle enzymes, including carbamoyl phosphate synthase 1 (CPS1), arginase 1 (ARG1), ornithine trans-carbamylase (OTC), and ODC. The putrescine levels in both HCT116 xenografts and HCT116 cells decreased after metformin treatment. These results demonstrate that metformin inhibited CRC cell proliferation via activating AMPK/p53 and that there was an association between metformin, urea cycle inhibition and a reduction in putrescine generation.
登录
查看更多内容
影响因子：
7.6
作者：
Dupont, A. W.;Arguedas, M. R.;Wilcox, C. M.
通讯作者：
Wilcox, C. M.
SWATH-MS 定量蛋白质组学揭示肝细胞癌组织中复杂的代谢重编程
影响因子：
4.6
作者：
Gao Y;Wang X;Sang Z;Li Z;Liu F;Mao J;Yan D;Zhao Y;Wang H;Li P;Ying X;Zhang X;He K;Wang H
通讯作者：
Wang H
影响因子：
6.2
作者：
Dillon, BJ;Prieto, VG;Clark, MA
通讯作者：
Clark, MA
癌症发动机的油：致癌信号传导和多胺代谢之间的串扰。
影响因子：
13.6
作者：
Arruabarrena-Aristorena A;Zabala-Letona A;Carracedo A
通讯作者：
Carracedo A
影响因子：
11.2
作者：
Feng, Zhaohui;Hu, Wenwei;Levine, Arnold J.
通讯作者：
Levine, Arnold J.